中国医学创新2015，Vol.12Issue(32)：50-52,3.DOI:10.3969/j.issn.1674-4985.2015.32.015
经皮椎体成形术后手术椎体再发骨折因素分析
Analysis of the Factors of Surgical Vertebral Recurrent Fractures after Percutaneous Vertebroplasty
摘要
Abstract
Objective:To analyze the risk factors of surgical vertebral recurrent fractures after percutaneous vertebroplasty(PVP),and to provide reference for the intervention measures.Method:149 patients(212 vertebral bodies) with vertebral compression fractures were treated with percutaneous vertebroplasty(PVP) in our hospital from January 2013 to June 2014 and followed up for 3-12 months,21 patients(29 vertebral bodies) were postoperative recurrence of fracture,the causes of recurrent fractures were analyzed.Result:The filling materials,postoperative average angle correction of high degree,activity of thoracic lumbar spine,low bone mineral density (T value),the initial fracture segments to T11-L2,did not receive the osteoporosis treatment were the influencing factors of PVP surgical vertebral recurrent fractures(P<0.05).Multivariate Logistic regression analysis showed that bone mineral density, thoracic and lumbar activity,postoperative average angle correction degree,initial fracture segment T11-L2were the main influence factors of PVP for the treatment of vertebral fracture,and anti osteoporosis treatment was surgical vertebral fracture protective factor(P<0.05).Conclusion:There are many risk factors of postoperative vertebral fractures in patients wth PVP,such as the patients' own factors,also have medical source factors.Therefore recommended angle correction cycle should be the degree according to patients with bone mineral density and avoid excessive correction and low bone mineral density (BMD) patients should reduce the thoracic and lumbar activity,and adhere to the anti osteoporosis drugs,to prevent or extend the period of the vertebral body fractures..关键词
经皮椎体成形术/手术椎体/再发骨折/因素Key words
Percutaneous vertebroplasty/Surgical vertebral body/Recurrent fractures/Factors引用本文复制引用
曾博,张慧琳,熊春,徐先..经皮椎体成形术后手术椎体再发骨折因素分析[J].中国医学创新,2015,12(32):50-52,3.基金项目
江西省卫生厅科技计划项目(20062053) （20062053）
